by
Kaya, İbrahim, author.
Format:
El Yazması
Alıntı:
Indentification and detection of cis-platin binding proteins by laser induced breakdown
by
Yaylak, Bilge, author.
Format:
El Yazması
Alıntı:
Biochemical and functional characterization of circular RNAs differentially expressed in cisplatin
by
Alkan, Ayşe Hale, author.
Format:
El Yazması
Alıntı:
investigated. Candidate lncRNAs from Doxorubicin, Fas mAB, TNF-alpha and Cisplatin treated HeLa cell line were
by
Kara, Merve, author.
Format:
El Yazması
Alıntı:
transcribed from their intronic promoter under cisplatin- and TNF-alpha- mediated apoptosis conditions. In
by
Yaylak, Bilge, author.
Format:
El Yazması
Alıntı:
/or global circRNAs in apoptotic HeLa cells. Cisplatin (CP), doxorubicin (DOX), Fas mAb(FAS) and
by
Ahmadov, Ulvi, author.
Format:
El Yazması
Alıntı:
%. Under our experimental setting, treatments with cisplatin, doxorubicin, Fas mAb and TNF-alpha led to the
by
Gürer, Dilek Cansu, author.
Format:
El Yazması
Alıntı:
, a transcriptomics study was performed under cisplatin, doxorubicin, TNF-α and Anti-Fas treatments
by
Yarımçam, Murat Caner, author.
Format:
El Yazması
Alıntı:
resemblance between GTF2A-1 antisense lncRNA silencing-induced apoptosis and cisplatin-induced apoptosis. The
by
Demir, Ayşe Banu, author.
Format:
El Yazması
Alıntı:
. Among these genes, only PDR5 overexpression was found to have cross-resistance to Cisplatin. Real-time
by
Kaçar, Vahide İlayda, author.
Format:
El Yazması
Alıntı:
novel long non-coding RNA (lncRNA) transcript that is cisplatin inducible and is involved in modulation
by
Çiftçi, Yusuf Cem, author.
Format:
El Yazması
Alıntı:
apoptosis in HeLa cells. Additionally, when GTF2A1-AS knockdown was combined with cisplatin, it sensitized
by
Telli, Kübra, author.
Format:
El Yazması
Alıntı:
Cisplatin. The clinical success of these inhibitors requires further examination of potential intrinsic or